DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will host an
Analyst and Investor Conference in New York City on Wednesday, November
8, 2017. Management will provide an update on the business and progress
since the merger. The presentations will begin at 9:00 a.m. ET and will
conclude at approximately 1:00 p.m. Registration is required to attend
the event.
All are invited to listen to the live event and view the presentation
slides via webcast on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com.
The discussion will also be available by dialing +1-800-672-6112 in the
U.S. and Canada, or +1-303-223-4370 for international callers.
A replay of the webcast will be available later that day, following the
conclusion of the live event. To access the webcast recording, visit http://ir.quintilesims.com.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated to
helping its clients improve their clinical, scientific and commercial
results. Formed through the merger of Quintiles Transnational and IMS
Health, QuintilesIMS’s approximately 50,000 employees conduct operations
in more than 100 countries. Companies seeking to improve real-world
patient outcomes through treatment innovations, care provision and
access can leverage QuintilesIMS’s broad range of healthcare
information, technology and service solutions to drive new insights and
approaches. QuintilesIMS provides solutions that span clinical to
commercial, bringing customers a unique opportunity to realize the full
potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS protects
individual privacy while managing information to drive healthcare
forward. These insights and execution capabilities help biotech, medical
device and pharmaceutical companies, medical researchers, government
agencies, payers and other healthcare stakeholders in the development
and approval of new therapies, and to identify unmet treatment needs and
understand the safety, effectiveness and value of pharmaceutical
products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171004006096/en/
Source: Quintiles IMS Holdings, Inc.